Log in to your Inderes Free account to see all free content on this page.

Medistim

Less than 1K followers

MEDI

Oslo Børs

Medical Equipment & Services

Health Care

Overview

Ownership

Investor consensus

Medistim is active in ultrasound technology. The company develops and commercializes medical equipment for use in cardiovascular and transplant surgery. The company strives to reduce risks and improve quality by using transit time flow measurement and high-frequency ultrasound imaging. Medistim has subsidiaries and distributors in markets around the world. Its customers are public and private hospitals and the company is headquartered in Norway.

Market cap

-

Turnover

-

Revenue

EBIT %

P/E

Dividend yield-%

All

Press releases

ShowingAll content types

Regulatory press release11/11/2025, 7:00 AM

MEDI: Management in Medistim ASA purchases shares

Regulatory press release11/10/2025, 7:00 AM

MEDI: Management in Medistim ASA purchases shares

Regulatory press release10/24/2025, 6:30 AM

MEDI: Financial results for the third quarter and YTD September 2025 for Medistim ASA

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account

Stock market's most popular morning newsletter

Analyst comments and recommendations

Stock comparison tool

PREMIUM account

All company reports and content

Premium tools (e.g. insider transactions & stock screener)

Model portfolio

Regulatory press release10/17/2025, 7:31 AM

MEDI: Third quarter and year-to-date September results and financials for 2025 for Medistim ASA

Regulatory press release9/12/2025, 8:56 AM

MEDI: Major shareholder disclosure

Regulatory press release8/20/2025, 6:00 AM

MEDI: Financial results for the second quarter and first half of 2025 for Medistim ASA

Regulatory press release8/13/2025, 6:00 AM

MEDI: First half and second quarter results and financials for 2025 for Medistim ASA

Regulatory press release6/20/2025, 8:41 AM

MEDI: Management and key personnel in Medistim ASA purchases shares

Regulatory press release5/28/2025, 12:05 PM

MEDI: CEO share program

Regulatory press release5/9/2025, 6:50 AM

MEDI: First quarter 2025 presentation for Medistim ASA

Regulatory press release5/9/2025, 6:30 AM

MEDI: Ex dividend NOK 6.00 today

Regulatory press release5/9/2025, 6:00 AM

MEDI: First quarter 2025 financial results and status for Medistim ASA

Regulatory press release5/8/2025, 8:30 AM

MEDI: The General Meeting in Medistim ASA decided a dividend of NOK 6.00 per share

Regulatory press release5/8/2025, 8:28 AM

MEDI: Protocol from General Meeting in Medistim ASA

Regulatory press release5/7/2025, 3:26 PM

MEDI: Disclosure of voting rights in Medistim ASA

Regulatory press release5/6/2025, 6:52 AM

MEDI: First quarter results and financials for 2025 for Medistim ASA

Regulatory press release4/24/2025, 1:58 PM

Medistim ASA - Share buyback program completed

Regulatory press release4/16/2025, 2:30 PM

Medistim ASA - Status on share buyback

Regulatory press release4/16/2025, 9:28 AM

Dividend proposal for 2024 Medistim ASA - Key information - Correction of record date

Regulatory press release4/15/2025, 3:55 PM

Dividend proposal for 2024 Medistim ASA - Key information

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.